A Phase I Study to Evaluate the Safety and Parmacokineti

Project: Research project

Description

A Phase I Study to Evaluate the Safety and Parmacokinetics of Panitumumab in Children with Solid Tumors
StatusFinished
Effective start/end date11/29/0712/30/15

Funding

  • Amgen Inc.

Fingerprint

Safety
Neoplasms
panitumumab